Zevra Therapeutics, Inc.
ZVRANasdaqCIK 1434647HealthcareFiscal year ends Dec 31
Reports and events: 274 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0521:19 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001434647-26-000068 |
| 2026-08-0520:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001434647-26-000067 |
| 2026-06-0520:19 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001434647-26-000041 |
| 2026-05-0621:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001434647-26-000031 |
| 2026-05-0620:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001434647-26-000029 |
| 2026-04-2013:00 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001434647-26-000025 |
| 2026-03-1611:31 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001434647-26-000015 |
| 2026-03-0920:23 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001434647-26-000011 |
| 2026-03-0920:06 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001434647-26-000009 |
| 2025-12-1721:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001434647-25-000018 |
| 2025-12-0212:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001434647-25-000015 |
| 2025-11-2021:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-289865 |
| 2025-11-0522:21 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001434647-25-000011 |
| 2025-11-0521:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001434647-25-000009 |
| 2025-08-1221:24 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-039967 |
| 2025-08-1220:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-039883 |
| 2025-05-2920:42 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-130714 |
| 2025-05-1321:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016523 |
| 2025-05-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016452 |
| 2025-04-0712:04 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-073991 |
| 2025-03-1221:23 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-007320 |
| 2025-03-1120:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-007032 |
| 2025-02-2712:38 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-037619 |
| 2024-12-0622:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-036876 |
| 2024-11-2223:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-035988 |
| 2024-11-1321:18 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034916 |
| 2024-11-1221:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034565 |
| 2024-09-2020:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-029747 |
| 2024-08-1421:36 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-026474 |
| 2024-08-1320:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-026397 |
| 2024-08-0921:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197943 |
| 2024-08-0820:09 ET | 8-K | 2.02 Results of operations | 0001193125-24-196961 |
| 2024-08-0523:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-024543 |
| 2024-07-1220:37 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-022668 |
| 2024-07-0913:23 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-022362 |
| 2024-06-0321:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-019074 |
| 2024-05-1320:47 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-016275 |
| 2024-05-0920:34 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-015705 |
| 2024-05-0811:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-015210 |
| 2024-04-1011:46 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure | 0001437749-24-011571 |
| 2024-04-0320:15 ET | DEF 14A | Proxy statementPeriod 2024-05-13 | 0001437749-24-010874 |
| 2024-04-0121:27 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-010430 |
| 2024-03-2820:35 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001437749-24-009849 |
| 2024-03-2700:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-009476 |
| 2024-03-0512:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-006540 |
| 2024-03-0413:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-006365 |
| 2024-02-2821:29 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-24-005904 |
| 2024-02-0522:54 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001437749-24-003003 |
| 2024-01-2312:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-001909 |
| 2024-01-0813:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001437749-24-000822 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.